Dalzanemdor | m-entrepreneurship.com

Product Name :
Dalzanemdor

Search keywords :
Dalzanemdor

drugId :
null

Target Vo:
Glutamate [NMDA] receptor

Target Vo Short Name :
NMDAR

Moa_Name:
Glutamate [NMDA] receptor modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Sage Therapeutics

Active Company_Name :
Sage Therapeutics

Active Indication_Name:
Huntington Disease

In Active Indication_Name:
Parkinson Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Etrolizumab Biological Activity
IKK alpha Rabbit mAb Protocol
DsbA Tag Antibody (YA868): DsbA Tag Antibody (YA868) is an unconjugated, approximately 23 kDa, mouse-derived, anti-DsbA Tag (YA868) monoclonal antibody. DsbA Tag Antibody (YA868) can be used for: WB expriments in Escherichia coli background without labeling.

Author: Betaine hydrochloride

Related Posts